Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 23, 2011

View Archived Issues

Pfizer describes identification of new drug for allergic rhinitis

VANTAGE 88 reveals activity of combination therapy for multiple myeloma

Biomarkers of kidney injury identified in patients with MM

Galectin Therapeutics reviews recent progress

AstraZeneca provides update on olaparib and TC-5214 programs

U.K. study uncovers new biomarker for bronchiolitis obliterans syndrome

Kissei presents new nonpurine adenosine A2A receptor antagonists

GSK begins phase IIa trial of GSK-2586881

DiaMedica's humanized MAb for type 2 diabetes shows improved binding affinity

Merck & Co. discloses new B-raf inhibitors

Novel GPR119 receptor agonists discovered in Japan

GlaxoSmithKline presents novel protein kinase inhibitors

New 11-beta-HSD1 inhibitors developed in Korea

Novel somatostatin sst5 receptor antagonists synthesized

ALS Therapy Development Institute collaborates with Biogen Idec and UCB

Topline phase III data presented on teriflunomide in MS

FDA issues update on Multaq review

Repligen completes acquisition

Clinuvel reports final data from phase III afamelanotide trial

Affibody and Nuclisome join forces to develop cancer therapeutics

TiGenix clear to begin phase I study of stem cell product

EMA validates MAA for single-tablet HIV-1 therapy

Galaczym obtains new orphan drug status

Salix Pharmaceuticals acquires Oceana Therapeutics

ImmunoGen and Lilly enter collaboration for antibody-based anticancer therapeutics

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...